Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 44% ± 12% | |
lung | 15 studies | 30% ± 13% | |
intestine | 8 studies | 35% ± 17% | |
lymph node | 5 studies | 30% ± 12% | |
kidney | 4 studies | 35% ± 9% | |
bone marrow | 4 studies | 29% ± 13% | |
uterus | 4 studies | 50% ± 11% | |
prostate | 4 studies | 20% ± 3% | |
breast | 4 studies | 43% ± 5% | |
pancreas | 3 studies | 21% ± 5% | |
skin | 3 studies | 27% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 2956.79 | 964 / 966 | 100% | 31.18 | 527 / 527 |
lung | 100% | 7870.81 | 577 / 578 | 99% | 24.90 | 1138 / 1155 |
stomach | 97% | 2213.59 | 348 / 359 | 99% | 29.49 | 283 / 286 |
breast | 99% | 1883.44 | 455 / 459 | 96% | 20.13 | 1075 / 1118 |
uterus | 99% | 1449.13 | 169 / 170 | 95% | 36.29 | 438 / 459 |
esophagus | 96% | 1545.66 | 1392 / 1445 | 96% | 24.25 | 176 / 183 |
thymus | 99% | 1869.79 | 648 / 653 | 91% | 15.68 | 550 / 605 |
liver | 99% | 1671.06 | 224 / 226 | 90% | 15.11 | 365 / 406 |
prostate | 100% | 2715.41 | 244 / 245 | 89% | 14.29 | 446 / 502 |
kidney | 100% | 1942.92 | 89 / 89 | 84% | 17.52 | 757 / 901 |
ovary | 88% | 1082.12 | 159 / 180 | 94% | 23.06 | 406 / 430 |
bladder | 86% | 1310.14 | 18 / 21 | 96% | 29.01 | 486 / 504 |
skin | 84% | 1006.28 | 1522 / 1809 | 76% | 21.98 | 361 / 472 |
pancreas | 48% | 505.33 | 158 / 328 | 99% | 21.28 | 176 / 178 |
adrenal gland | 90% | 1266.76 | 232 / 258 | 44% | 4.11 | 102 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 68.06 | 29 / 29 |
peripheral blood | 100% | 9263.14 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 8291.43 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 47.23 | 45 / 45 |
adipose | 99% | 2580.84 | 1192 / 1204 | 0% | 0 | 0 / 0 |
heart | 83% | 977.91 | 711 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 73% | 838.91 | 980 / 1335 | 0% | 0 | 0 / 0 |
brain | 22% | 269.99 | 586 / 2642 | 44% | 5.70 | 307 / 705 |
muscle | 42% | 382.94 | 334 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 28% | 6.37 | 22 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0002376 | Biological process | immune system process |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0032728 | Biological process | positive regulation of interferon-beta production |
GO_0071260 | Biological process | cellular response to mechanical stimulus |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_2000564 | Biological process | regulation of CD8-positive, alpha-beta T cell proliferation |
GO_0051607 | Biological process | defense response to virus |
GO_0032735 | Biological process | positive regulation of interleukin-12 production |
GO_0034124 | Biological process | regulation of MyD88-dependent toll-like receptor signaling pathway |
GO_0060333 | Biological process | type II interferon-mediated signaling pathway |
GO_0032481 | Biological process | positive regulation of type I interferon production |
GO_0002819 | Biological process | regulation of adaptive immune response |
GO_0035458 | Biological process | cellular response to interferon-beta |
GO_0045088 | Biological process | regulation of innate immune response |
GO_0043374 | Biological process | CD8-positive, alpha-beta T cell differentiation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006915 | Biological process | apoptotic process |
GO_0045590 | Biological process | negative regulation of regulatory T cell differentiation |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0005515 | Molecular function | protein binding |
Gene name | IRF1 |
Protein name | Interferon regulatory factor 1 (IRF-1) Interferon regulatory factor 1 isoform I4 Interferon regulatory factor 1 Interferon regulatory factor |
Synonyms | hCG_24115 IRF-1 |
Description | FUNCTION: Transcriptional regulator which displays a remarkable functional diversity in the regulation of cellular responses . Regulates transcription of IFN and IFN-inducible genes, host response to viral and bacterial infections, regulation of many genes expressed during hematopoiesis, inflammation, immune responses and cell proliferation and differentiation, regulation of the cell cycle and induction of growth arrest and programmed cell death following DNA damage . Stimulates both innate and acquired immune responses through the activation of specific target genes and can act as a transcriptional activator and repressor regulating target genes by binding to an interferon-stimulated response element (ISRE) in their promoters . Competes with the transcriptional repressor ZBED2 for binding to a common consensus sequence in gene promoters . Its target genes for transcriptional activation activity include: genes involved in anti-viral response, such as IFN-alpha/beta, RIGI, TNFSF10/TRAIL, ZBP1, OAS1/2, PIAS1/GBP, EIF2AK2/PKR and RSAD2/viperin; antibacterial response, such as GBP2, GBP5 and NOS2/INOS; anti-proliferative response, such as p53/TP53, LOX and CDKN1A; apoptosis, such as BBC3/PUMA, CASP1, CASP7 and CASP8; immune response, such as IL7, IL12A/B and IL15, PTGS2/COX2 and CYBB; DNA damage responses and DNA repair, such as POLQ/POLH; MHC class I expression, such as TAP1, PSMB9/LMP2, PSME1/PA28A, PSME2/PA28B and B2M and MHC class II expression, such as CIITA; metabolic enzymes, such as ACOD1/IRG1 . Represses genes involved in anti-proliferative response, such as BIRC5/survivin, CCNB1, CCNE1, CDK1, CDK2 and CDK4 and in immune response, such as FOXP3, IL4, ANXA2 and TLR4 . Stimulates p53/TP53-dependent transcription through enhanced recruitment of EP300 leading to increased acetylation of p53/TP53 . Plays an important role in immune response directly affecting NK maturation and activity, macrophage production of IL12, Th1 development and maturation of CD8+ T-cells . Also implicated in the differentiation and maturation of dendritic cells and in the suppression of regulatory T (Treg) cells development . Acts as a tumor suppressor and plays a role not only in antagonism of tumor cell growth but also in stimulating an immune response against tumor cells . . |
Accessions | ENST00000680237.1 ENST00000680352.1 ENST00000681584.1 X5D3F6 A0A1B1RS94 A0A7P0TAL6 A0A7P0T7Z4 ENST00000437654.6 A0A0B6XK11 ENST00000681694.1 R4GNI0 B4DQF0 A0A7P0TAD7 ENST00000458069.5 ENST00000679440.1 ENST00000613424.5 A0A510GDD8 ENST00000681336.1 P10914 A0A7P0T8P0 ENST00000679860.1 ENST00000679921.1 ENST00000681595.1 V9P8K4 A0A0B6XK53 C9J9C5 V9P921 ENST00000680139.1 ENST00000680903.1 A0A7P0TAZ9 ENST00000681749.1 ENST00000679633.1 ENST00000439555.2 A0A7P0TAJ7 ENST00000680796.1 ENST00000681462.1 A0A7P0TAU2 ENST00000679700.1 ENST00000681458.1 ENST00000476613.1 C9JD95 A0A7P0T8F2 A0A7P0TBL0 ENST00000679743.1 A0A7P0T8D8 A0A7P0Z474 ENST00000680562.1 Q5FBX3 ENST00000681240.1 A0A7P0TAS9 ENST00000245414.9 A0A7P0Z4G2 A0A7P0T9Q9 ENST00000405885.6 A0A7P0TBA1 ENST00000679499.1 ENST00000681715.1 A0A7P0T9W2 Q6FHN8 F8WCM1 A0A7P0TAS4 A0A7P0TAY3 |